88 results on '"Bassendine, M."'
Search Results
2. Immune basis for PBC
3. Primary Biliary Cirrhosis
4. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
5. Hepatitis C virus (HCV) and atherosclerosis risk: A role for low-density immune complexes?
6. P0725 : Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection
7. Infectious aetiology of primary biliary cirrhosis?
8. Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency
9. PTU-115 Hepatitis B in Pregnancy: what Happens to the Infants?
10. PWE-116 Liver Stiffness Measurement Predicts Response to Anti-Viral Treatment in Patients with Chronic Hepatitis C Genotype 3
11. 476 LIVER STIFFNESS MEASUREMENT ASSESSED BY FIBROSCAN PREDICTS RESPONSE TO ANTI-VIRAL TREATMENT IN PATIENTS WITH GENOTYPE 2 AND 3 CHRONIC HEPATITIS C
12. Targeted case finding for hepatitis B using dry blood spot testing in the British–Chinese and South Asian populations of the North‐East of England
13. Lipids and HCV
14. PMO-171 A pilot of targeted case finding for hepatitis B virus (HBV) and hepatitis C (HCV) in the British South Asian community
15. PMO-162 Pregnant mothers with chronic hepatitis B (HBV): how often is treatment needed?
16. P18 Liver fibrosis assessed by transient elastography predicts response in chronic hepatitis C infected patients treated with PEG-Interferon and Ribavirin
17. P50 Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic hepatitis C infection: evidence for genotype-specific modulation of lipid pathways
18. P54 CHASE-B (Chinese Hepatitis Awareness, Surveillance and Education): a pilot of targeted case finding for hepatitis B virus (HBV) in the British-Chinese community
19. P44 Use of Intralipid infusion to analyse apolipoprotein B (apoB) and HCV RNA kinetics in chronic infection
20. The 'interferon paradox' as a predictor of non-response to anti-viral therapy: novel association with apolipoprotein E and hepatitis C virus (HCV) lipoviralparticles (LVP).
21. Depression in chronic hepatitis C is associated with low apolipoprotein e levels
22. Undiagnosed chronic hepatitis B is prevalent in the british-chinese community of the north east (NE) of england
23. 381 UNDIAGNOSED CHRONIC HEPATITIS B IS PREVALENT IN THE BRITISH-CHINESE COMMUNITY OF THE NORTH EAST (NE) OF ENGLAND
24. 473 DEPRESSION IN CHRONIC HEPATITIS C IS ASSOCIATED WITH LOW APOLIPOPROTEIN E LEVELS
25. 1183 THE “INTERFERON PARADOX” AS A PREDICTOR OF NON-RESPONSE TO ANTI-VIRAL THERAPY: NOVEL ASSOCIATION WITH APOLIPOPROTEIN E AND HEPATITIS C VIRUS (HCV) LIPOVIRAL PARTICLES (LVP)
26. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection
27. 714 COLLABORATIVE UK STUDY OF CHRONIC HEPATITIS B VIRUS INFECTION
28. Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin
29. 869 CHARACTERIZATION OF HEPATITIS C VIRUS PARTICLES IN HUMAN PLASMA: ASSOCIATION WITH IMMUNOGLOBULINS G1, G3 & M AND APOLIPOPROTEINS A-I, A-II, B, C-I AND E
30. Nucleoside analogue therapy in fibrosing cholestatic hepatitis - a case report in an HBsAg positive renal transplant recipient
31. Distribution of genotypes and drug resistance mutations in patients with chronic hepatitis b virus (HBV) infection in north east (NE) England
32. Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis
33. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis
34. Rolling review: autoimmune liver disease
35. Chemokine receptor 5 and primary biliary cirrhosis: a two-centre genetic association study
36. Hepatitis associated with Chinese herbs
37. Osteoporosis in primary biliary cirrhosis revisited
38. Vitamin D receptor (VDR) TaqI polymorphism in primary biliary cirrhosis (PBC)
39. Is the revised international autoimmune hepatitis group (IAHG) scoring system useful?
40. Secretory autoantibodies in primary biliary cirrhosis (PBC)
41. T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)
42. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease
43. Hepatitis G virus does not cause significant liver disease after liver transplantation
44. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes
45. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
46. Outcome of post-transfusion hepatitis C: disease severity in blood- component recipients and their implicated donors
47. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis
48. T cell responses to natural human proteins in primary biliary cirrhosis
49. T cell responses to tuberculin purified protein derivative in primary biliary cirrhosis: evidence for defective T cell function.
50. Primary biliary cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.